Protein Detection And Quantification Market (2026 - 2033)

Protein Detection And Qualification Market Summary

The global protein detection and quantification market size was valued at USD 3.2 billion in 2025 and is projected to grow from USD 3.5 billion in 2026 to USD 6.2 billion in 2033, at a CAGR of 8.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The market growth is driven by demand for proteomics research, which is needed to expand knowledge of protein interactions, functions, and modifications.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

There is an increase in demand for personalized medicine and diagnostics, as patients with high disposable incomes are willing to invest more to access better treatments. Protein detection and quantification are essential for drug identification and optimizing compound leads.

There has been an increase in government and key medical institutions' investments in proteomics research and development. Protein is an important part of the human body, as it performs essential functions such as transporting substances, catalyzing enzymatic reactions, and storing molecules. The detection and quantification of proteins are essential, as they aid in identifying biomarkers, advancing drug development, and diagnosing illnesses.

There is an increased prevalence of chronic diseases such as neurological disorders, cancers, and diabetes. Detecting and quantifying proteins is crucial for diagnosing and treating diseases, as proteins affect the development and progression of different health conditions. Medical research companies and governments are investing heavily in improving the treatment of chronic diseases through protein detection and quantification.

Furthermore, increased demand for personalized medicine is driving market revenue growth. Tailoring patient care based on genetic and molecular profiles is growing rapidly. This approach requires identifying specific biomarkers, such as proteins or other compounds, that can indicate the existence of a disease or predict an individual's reaction to a particular treatment. Hence, these factors have resulted in the growth of this market.

Analyst Perspective

The global protein detection and quantification market is experiencing steady growth. This expansion is driven by increased investments in proteomics, precision medicine, and biomarker discovery. Colorimetric assays maintain a strong market share because they are affordable and easy to use. They remain a staple for routine protein estimation across clinical and research laboratories. Meanwhile, growing demand for higher accuracy and throughput is accelerating advanced tech adoption. Fluorescence-based assays, modern immunoassays, and automated platforms are gaining rapid traction. Expanding applications in diagnostics, biotech, and pharmaceutical research further fuel this momentum. Ultimately, companies investing in automation and next-gen proteomics will secure a strong competitive edge.

Technology Insights

The colorimetric assays segment dominated the market in 2025, with a share of over 25.0% in 2025. The market growth is attributed to the increased preference for colorimetric assays in clinical research laboratories due to their functionality, wide availability of reagents, and low cost. A colorimetric assay is preferred for large-scale protein quantification. Colorimetric assay relies on color changes resulting from reactions between the protein and reagents.

The immunological methods segment is expected to grow during the forecast period. This market growth is attributed to increased demand for immunological methods, which aid in the specific detection of proteins. This method also helps identify and measure proteins from complex mixtures. Therefore, these factors contribute to the positive market growth of this segment.

Product Insights

The kits and reagents/consumables segment dominated the market in 2025, with a share of over 60.0%. This market growth is attributed to the rising use of reagents and consumables for protein detection and quantification. Kits ensure accuracy and reliability for research and diagnosis. Major companies are investing heavily in the research and development of kits to improve their output and sensitivity. Furthermore, the availability of a wide range of kits aids research on protein detection and quantification.

The services segment is projected to grow significantly during the forecast period. This market growth is attributed to increased demand for accurate protein detection and quantification across applications such as drug development, biomarker identification, and disease diagnosis. Researchers outsource protein detection processes to experts to improve the quality of results. Hence, these factors have driven growth in this segment of the market.

Application Insights

The drug discovery and development segment dominated the market, with a share of over 45.0% in 2025. This market growth was due to increased government and major medical facility investments in research and developing new, effective drugs. For instance, in September 2025, SCIEX introduced native fluorescence detection for its BioPhase 8800 System, increasing the sensitivity of protein-based capillary electrophoresis assays for protein characterization and quantitative analysis. This advancement enables more accurate protein analysis in biopharmaceutical research and streamlines drug discovery and development.

Due to the rise in chronic illnesses such as cancer and brain disorders, there is an increased demand for drugs that are more effective and have fewer side effects. Furthermore, the demand for personalized drug treatment has also resulted in the market, as patients are willing to invest heavily to have a tailor-made therapy based on their genetics. Therefore, these factors have resulted in market growth of this segment.

The clinical diagnosis segment is expected to grow during the forecast period. This market growth is attributed to the increase in the number of patients with chronic illnesses and heavy investments by the government and medical facilities in research and development to improve patient diagnosis and treatment. There is an increase in protein detection and quantification processes, which are essential for disease diagnosis and treatment and can lead to accurate, effective treatment over the course of the illness. Hence, these factors have been attributed to the growth of this segment's market.

End Use Insights

The hospitals and diagnostic centers segment dominated the market in 2025, with a share of over 45.0%. This growth was due to the increased number of patients with chronic illnesses and the need for new drug discovery and development. An increase in biomarker identification and disease diagnosis has driven growth in this segment. Furthermore, growth in the healthcare sector and increased investment by the government and major healthcare institutions in research and development to develop new drugs and treatments have driven growth in this segment.

The contract research organizations segment is anticipated to grow significantly during the forecast period. This market growth is attributed to increased demand for protein detection and quantification for research. Contract research organizations have technologically advanced equipment for improved protein detection and quantification, with faster turnaround and greater accuracy. Researchers prefer to outsource the process due to a lack of a qualified workforce and to improve time management. Therefore, these factors contribute to the market growth of this segment.

Regional Insights

North America dominated the protein detection and quantification market with a market share of approximately 35.0% in 2025. This market growth resulted from the presence of major biotechnology and pharmaceutical companies and their significant investments in research and development to drive innovations in drug discovery and treatment. This robust research ecosystem supports the adoption of advanced protein analysis technologies in the region. For instance, in January 2026, Bio-Techne launched the Simple Plex Ultra-Sensitive Assays on its Ella platform, enabling femtogram-level detection and quantification of neurological protein biomarkers.

To learn more about this report, Download Free Sample Report

In addition, there is an increase in the occurrences of chronic illnesses such as cancer, diabetes, and brain illnesses. This has increased demand for treatments with better efficiency and fewer side effects. Hence, the region has an increasing demand for advanced technologies for protein detection and quantification.

U.S. Protein Detection & Quantification Market Trends

The U.S. held a substantial market share in the North America protein detection and quantification market due to a developed healthcare sector and increased government and medical institutes' investments to develop new and effective drugs. Populations with high disposable incomes have seen an increase in the adoption of personalized medications. Furthermore, the developed healthcare infrastructure facilitates better research due to the presence of technologically advanced equipment in the country. Therefore, these factors drive the growth of this segment.

Europe Protein Detection & Quantification Market Trends

Europe protein detection and quantification market was identified as a lucrative region in this industry, as it had a market share of approximately 30.0% in 2025. This growth resulted from the presence of major pharmaceutical and biotechnology companies and their heavy investments in research and development to develop new drugs and treatments. The increased prevalence of chronic illnesses has resulted in an increased demand for effective drugs in the region. There is an increase in the demand for better technology to detect and quantify proteins in this region. Hence, these factors contribute to the market growth in this region.

The UK protein detection and quantification market is expected to grow rapidly due to increased government and major medical institute investments in researching and developing new, effective drugs using protein detection and quantification. Furthermore, increased disposable income among the population has increased demand for personalized medication and treatment. Therefore, these factors have contributed to the market growth in this region.

Asia Pacific Protein Detection & Quantification Market Trends

Asia Pacific held a market share of over 25.0% in 2025, owing to the increasing emphasis on drug development and personalized medicine, along with the growing healthcare industry in countries such as China, India, and Japan. Government and private organizations are increasing their investments in research and development to meet the growing demand for effective treatments. Furthermore, the rising occurrence of chronic illnesses such as cancer and diabetes has further resulted in market growth in this region.

China dominated the Asia Pacific market in 2025. The factors driving market growth in the country are the rising prevalence of chronic illnesses and the growing demand for improved medical treatments. The market is also growing due to growth in the healthcare sector. Furthermore, the growth of the population with high disposable incomes has led to increased demand for personalized medicines and treatments. Hence, these factors have driven growth in the market for protein detection and quantification in this country.

Key Protein Detection And Quantification Company Insights

Some of the major companies in the protein detection and quantification market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, General Electric Company, and more. Companies are investing in research and development to launch innovative products that improve efficiency and optimize protein detection.

Key Protein Detection And Quantification Companies

The following key companies have been profiled for this study on the protein detection and quantification market:

• Agilent Technologies Inc.

• Bio-Rad Laboratories Inc.

• Danaher Corporation

• Merck KGaA

• PerkinElmer

• RayBiotech, Inc.

• Shimadzu Corporation

• Thermo Fisher Scientific Inc.

• Abcam Limited

• Promega Corporation

Recent Developments

• In September 2025, Illumina launched Illumina Protein Prep, a next-generation sequencing (NGS) based proteomics solution that measures up to 9,500 unique human protein targets. This platform offers large-scale, high-throughput protein detection and quantification through a streamlined workflow, supporting biomarker discovery, drug development, and clinical research.

• In March 2025, Bio-Techne launched the Leo System, a next-generation high-throughput Simple Western platform that automates protein size separation, detection, and quantification. The system processes up to 100 samples in three hours, significantly increasing throughput, reproducibility, and analytical-grade protein quantitation to support drug discovery and biopharmaceutical development.

• In January 2024, Agilent Technologies Inc. announced the launch of the Agilent ProteoAnalyzer System, an automated parallel capillary electrophoresis system for protein analysis to analyze complex protein mixtures.

Global Protein Detection And Quantification Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global protein detection and quantification market report based on technology, product, application, end use, and region:

• Technology Outlook (Revenue, USD Billion, 2021 - 2033)

  • Colorimetric Assays

  • Immunological Methods

  • Chromatography

  • Mass Spectrometry

  • Others

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Kits and Reagents/Consumables

  • Instruments

  • Services

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Drug Discovery and Development

  • Clinical Diagnosis

  • Others

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Academic Research Institutes

  • Biotechnology and Pharmaceutical Companies

  • Contract Research Organizations

  • Hospitals and Diagnostic Centers

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait